Skip to content

UiPath

US · PATH #1806 by market cap Listed 2021
10.96 -0.27 -2.40%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

Price chart

Pre-market 11.19 -0.36%
After-hours 11.08 +1.09%
Overnight 11.10 -1.16%
18.679.9310.962026-05-262026-11-20
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on PATH?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Neutral
  • Recent price momentum is -22.5% on average (3-month/1-year).
  • Main-fund capital flow has been a net outflow over the last 45 sessions.
  • Short interest has fallen to 18.8% of float.
  • Analyst tilt is Hold.
Quant Technical Outlook Bearish
  • Price is below its 20-day average and below its 60-day average.
  • The 20-day average is below the 60-day average, a short-term downtrend.
Quant Rating, last 30 days D → D

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Factor grades

Ranked against 2848 U.S. stocks StockVane covers.

Last computed: 2026-11-22 08:27 UTC

Data coverage: 6 of 6 factors. Missing data is not a zero score.

Overall B
ValuationGrowthProfitMomentumHealthAnalyst
Valuation C-

How expensive the stock is versus earnings, sales and its own 5-year history.

P/E (TTM) 16.4x Better than 54%
Forward P/E 30.3x Better than 18%
Price / Sales 4.0x Better than 29%
P/E vs own 5-yr range 81st pctl Better than 25%
Growth A

How fast revenue, profit and free cash flow are compounding.

Revenue CAGR (3Y) 15.0% Better than 75%
Free cash flow CAGR (3Y) 123.9% Better than 95%
Profitability B+

How much profit the business keeps from each dollar of sales and capital.

Gross margin 83.2% Better than 92%
Operating margin 3.5% Better than 30%
Net margin 17.5% Better than 76%
Return on equity 14.4% Better than 67%
Return on invested capital 12.4% Better than 77%
Momentum C

Recent price strength, skipping the latest month to avoid short-term noise.

3-month return -33.1% Better than 16%
6-month return 0.3% Better than 56%
12-month return (ex latest month) 8.6% Better than 45%
Distance below 52-week high 44.8% Better than 24%
Financial Health A-

Balance-sheet strength: leverage, liquidity and interest coverage.

Current ratio 2.5x Better than 66%
Debt to assets 2.6% Better than 86%
Free cash flow / net income 124.7% Better than 54%
Analyst View C

What the Street thinks: share of Buy ratings and upside to the average target.

Analysts rating Buy 14.3% Better than 7%
Upside to average target 41.9% Better than 60%

Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.

Performance

1W -17.41%
1M -18.39%
3M -31.16%
6M +1.76%
YTD -33.13%
1Y -13.90%
3Y -40.92%
5Y -79.15%

Key statistics

Price & volume

Prev close
11.23
Open
11.12
Day range
10.88 - 11.49
Avg price
11.09
Volume
29.86M
Turnover
331.22M
Amplitude
5.43%
52-week range
9.20 - 19.84

Valuation

P/E
21.08
P/E (TTM)
16.36
P/B
2.93
EPS
0.52
Net profit
271.00M
Net assets
1.95B

Share structure

Market cap
5.71B
Float cap
4.26B
Shares out
521.16M
Float shares
388.94M

Dividend & listing

Dividend (TTM)
0.00
Listing date
2021-04-21
52-week range 17% of range
9.20 19.84

44.8% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

-76.25M net over the window

Short interest

Shares short
97.82M
As of
2026-10-30

Frequently asked questions

What is the current stock price of UiPath (PATH)?

UiPath last traded at 10.96. This page shows a periodic quote snapshot. Check the displayed quote time.

What is UiPath's market cap?

About 5.71B.

What is the P/E ratio of UiPath?

The trailing twelve-month P/E is 16.36. The Valuation tab shows it against the stock's own five-year range.

Does UiPath pay a dividend?

UiPath does not currently pay a regular dividend.

Is UiPath a buy according to analysts?

The consensus of 14 analysts is a Hold rating, with an average 12-month price target of 15.55, which implies 41.9% upside from the current price. This is not investment advice.

What is UiPath's StockVane Quant Rating?

The StockVane Momentum strategy currently rates UiPath a D (Sell). Below its 200-day average or in the bottom third on momentum — the strategy is out of it. Not investment advice.

Quote time 2026-11-20 20:02:41 · For reference only, not investment advice and not tailored to your situation.

UiPath discussion 0 comments

Add a comment